Publisher
The Japanese Society of Physical Fitness and Sports Medicine
Reference56 articles.
1. 1) Ryall JG, Sillence MN and Lynch GS. 2006. Systemic administration of β2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. Br J Pharmacol 147: 587-595.
2. 2) Sato S, Nomura S, Kawano F, Tanihata J, Tachiyashiki K and Imaizumi K. 2008. Effects of the β2-agonist clenbuterol on β1- and β2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles. J Pharmacol Sci 107: 393-400.
3. 3) Kitaura T, Tsunekawa N and Kraemer WJ. 2002. Inhibited longitudinal growth of bones in young male rats by clenbuterol. Med Sci Sports Exerc 34: 267-273.
4. 4) Sneddon AA, Delday MI and Maltin CA. 2000. Amelioration of denervation-induced atrophy by clenbuterol is associated with increased PKC-alpha activity. Am J Physiol Endocrinol Metab 279: E188-E195.
5. 5) Petrou M, Wynne DG, Boheler KR and Yacoub MH. 1995. Clenbuterol induces hypertrophy of the latissimus dorsi muscle and heart in the rat with molecular and phenotypic changes. Circulation 92(9 Suppl): II483-489.